The current NVUS market cap is 353.29M. The company's latest EPS is USD -1.6665 and P/E is -1.30.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -10.6M | -58.69M | -11.11M | -10.35M | -11.2M |
Net Income | -10.47M | -58.38M | -10.77M | -9.58M | -10.35M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -16.05M | -18.47M | -36.87M | -88.43M | -43M |
Net Income | -16.01M | -22.81M | -34.51M | -87.97M | -40.33M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 149.59M | 92.79M | 82.31M | 106.79M | 96.07M |
Total Liabilities | 8.49M | 8.61M | 7.51M | 6.84M | 4.73M |
Total Equity | 141.09M | 84.18M | 74.79M | 99.95M | 91.34M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 10.93M | 197.19M | 170.55M | 92.79M | 89.07M |
Total Liabilities | 1.47M | 6.59M | 6.55M | 8.61M | 5.65M |
Total Equity | 9.47M | 190.6M | 164M | 84.18M | 83.42M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -18.94M | -28.42M | -9.92M | -18.15M | -30.4M |
Investing | N/A | N/A | N/A | -30.33M | -55.36M |
Financing | N/A | N/A | N/A | 33.02M | 33.02M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -13.86M | -15.21M | -28.91M | -28.42M | -39.53M |
Investing | N/A | 11.04M | N/A | N/A | -45.29M |
Financing | 9.68M | 109.58M | -449k | N/A | 33.02M |
Market Cap | 353.29M |
Price to Earnings Ratio | -1.30 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 11.33 |
Price to Book Ratio | 0.63 |
Dividend Yield | - |
Shares Outstanding | 24.2M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 6.35 (30.24%) |
Company Name | Novus Therapeutics Inc |
Address |
8 the green dover, delaware 19901 |
Website | https://www.eledon.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.